A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (NCT05433584)
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
๐ฉบ Plain-English Summary (8th-Grade Level)
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing treatment options when treatment is initiated early.
Who can join: Review the eligibility criteria below.
Location: Cahaba Research - Trussville โ Birmingham, Alabama
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (90 Sites)
Showing the first 25 of 90 sites.
- Cahaba Research - Trussville โ Birmingham, Alabama
- San Fernando Valley Health Institute โ Canoga Park, California
- Velocity Clinical Research, Huntington Park โ Huntington Park, California
- Velocity Clinical Research, San Diego โ La Mesa, California
- Clinical Trials Research โ Lincoln, California
- Velocity Clinical Research, Westlake โ Los Angeles, California
- Catalina Research Institute, LLC โ Montclair, California
- Velocity Clinical Research, North Hollywood โ North Hollywood, California
- Velocity Clinical Research, Panorama City โ Panorama City, California
- Western University of Health Sciences โ Pomona, California
- Velocity Clinical Research, Santa Ana โ Santa Ana, California
- New England Research Associates, LLC โ Bridgeport, Connecticut
- Excel Medical Clinical Trials โ Boca Raton, Florida
- Alliance for Multispecialty Research, LLC โ Coral Gables, Florida
- South Florida Clinical Research Institute โ Margate, Florida
- Emory University School of Medicine- Grady Campus โ Atlanta, Georgia
- Center for Advanced Research & Education โ Gainesville, Georgia
- Qualmedica Research, LLC โ Evansville, Indiana
- Iowa Diabetes and Endocrinology Research Center โ West Des Moines, Iowa
- Qualmedica Research โ Bowling Green, Kentucky
- NECCR PrimaCare Research โ Fall River, Massachusetts
- SKY Integrative Medical Center/SKYCRNG โ Ridgeland, Mississippi
- StudyMetrix Research โ City of Saint Peters, Missouri
- Clinvest Research LLC โ Springfield, Missouri
- Research Foundation of SUNY - University of Buffalo โ Buffalo, New York
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes
- Continuous Glucose Monitoring System Feasibility in Youth With T2D โ San Francisco, California
- Diabetes Nutrition Education and Healthy Food Resource for AIANs With T2D โ Oklahoma City, Oklahoma
- Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus โ Minneapolis, Minnesota
- Diabetes Medical Nutrition Therapy in Southeastern African American Women โ Nashville, Tennessee
- E3 Diabetes - Closing the Gap in Diabetes Control โ Chicago, Illinois
- Recreational Basketball to Increase Participation in Diabetes Prevention โ Atlanta, Georgia
Explore by condition: All Type 2 Diabetes clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.